• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Cannabis

New York State's Original 10 Cannabis Companies Are Big Winners

New York became the 16th state to legalize adult use cannabis.
By DEBRA BORCHARDT
Mar 31, 2021 | 01:00 PM EDT
Stocks quotes in this article: ACRHF, CCHWF, CRLBF, CURLF, ITHUF, GTBIF, MMNFF, VREOF, MJ

New York became the 16th state to legalize adult use cannabis as lawmakers passed the MRTA (Marijuana Regulation and Tax Act) this week. The bill will now go on to Governor Cuomo to sign, which he is expected to do. It will take at least a year to establish the program and sales aren't expected until 2022. However, the original growers, or OG's, in New York will be given many advantages to the market versus new entrants.

Original Grower's Stand To Gain

Viridian Capital Advisors said that New York will quickly become the biggest cannabis market on the East Coast and it forecasts that sales will reach $1.9 billion by 2025. New York was a limited license state with just 10 licenses awarded to medical marijuana operators. They include Acreage Holdings (ACRHF) , Columbia Care (CCHWF) , Cresco (CRLBF) , Curaleaf (CURLF) , iAnthus (ITHUF) , Etain Health (private), Green Thumb Industries (GTBIF) , MedMen (MMNFF) (whose assets have mostly been sold to privately held Ascend Wellness), PharmaCann (private) and Vireo Health (VREOF) . As with many other fully legal states, the original medical license holders stand to have the early advantage.

Viridian pointed out that the existing operators will be grandfathered in with several long-term advantages, creating an unequal playing field for new entrants. The company writes, "Today, existing license holders are permitted to have four medical dispensaries and are required to be vertically integrated. Under the new law, the license holders can open four more dispensaries with three of eight to be permitted for recreational sales. All new entrants to the market will be capped at three total stores." Vertical integration for new entrants will not be allowed forcing new players to either declare themselves fully retail or wholesalers. The existing license holders will also have the opportunity to expand and increase production.

"Using rough Massachusetts pricing ($4500/lbs. flower retail and $3000 wholesale) and cost of production ($1200/lbs. flower) as a proxy for New York, the existing New York license holders can achieve a 73% gross margin on the sale of one pound of flower while a non-vertically integrated retailer achieves 33%," read a new report by Viridian. "Meanwhile, a strictly wholesale operator gets 60%. This margin comes before factoring in the states planned excise tax based on THC content level. The excise tax is the burden of the distributor and incurred by the wholesale producer but likely partially passed on as part of the wholesale price. It appears that this cost will not be incurred for inhouse sales for vertically integrated operators widening the margin gap." Wholesales in Massachusetts like Ayr Wellness and Tilt Holdings have demonstrated that this side of the business can be quite lucrative.

The current licensees in the state could expect to see the existing medical operations remain solid revenue sources, although some stores could be sold off in a hot market.

Buying Opportunity

Viridian wrote, "We continue to anticipate significant interest amongst MSOs in obtaining licenses. In particular, we expect MSOs to focus either on retail operations near New York City or other populous parts of the state or to operate as wholesalers to the market." Licenses that are available for sale will no doubt command premium prices.

With all that being said Viridian analyst Jonathan DeCourcey believes there is a buying opportunity here: "Since early February cannabis stocks are down significantly (-23%) as reflected by the Alternative Harvest ETF (MJ) . This compares with a 4% decline for the Russell 2000 and a 1% gain for the S&P 500. While cannabis stocks are still very much outperforming YTD (+55%,versus 13% and 7%, respectively), we feel that the recent underperformance presents an attractive buying opportunity for investors particularly investors considering companies for which the macro improvements are significantly more attractive today than they were at the start of the year."

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Debra Borchardt had no position in the securities mentioned.

TAGS: Investing | Markets | Stocks | Trading | Cannabis

More from Cannabis

Doug Kass: Cannabis Stocks Are Still Not SAFE

Doug Kass
Dec 20, 2022 11:15 AM EST

Though it is tempting, there are a host of reasons why I'm not bottom fishing.

Cannabis ETFs Could Soon Turn a New Leaf

Mark Abssy
Dec 8, 2022 1:11 PM EST

With likely passage of new legislation, the pot industry might have a remedy for the nausea it gave investors.

3 Market Sectors Are Likely to Be Most Impacted by the Midterm Election

James "Rev Shark" DePorre
Nov 8, 2022 6:22 AM EST

The focus is on positioning for the election and CPI Thursday.

I'm Monitoring a Cannabis ETF That's Showing Signs of Bottoming

Bob Byrne
Nov 7, 2022 8:04 AM EST

It's a dicey play as the price action isn't defined as yet and the ETF still could break lower.

If You're High on Tilray, Invest for the Long Term

Stephen Guilfoyle
Oct 7, 2022 11:06 AM EDT

TLRY is probably not that close to sustained profitability, but it has built the balance sheet to tough out these hard times.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:48 AM EST REAL MONEY

    Watch Doug Kass on the Daily Rundown!

    In today's Action Alerts PLUS Daily Rundown, Doug ...
  • 11:03 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend On Real Money

    It's time to start using this power to build great...
  • 03:06 PM EST BOB LANG

    LEAPS Webinar

    This week, I offered a free webinar session talkin...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login